OMALIZUMAB

UNII:	2P471X1Z11
Formula:
Preferred Substance Name:	OMALIZUMAB

242138-07-4
CTP39
CTP-39
CT-P39
GBR 310
GBR-310
IGE25
IMMUNOGLOBULIN G (HUMAN-MOUSE MONOCLONAL E25 CLONE PSV1E26 -CHAIN ANTIHUMAN IMMUNOGLOBULIN E FC REGION), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL E25 CLONE PSVIE126 -CHAIN, DIMER
IMMUNOGLOBULIN G, ANTI-(HUMAN IMMUNOGLOBULIN E FC REGION) (HUMAN-MOUSE MONOCLONAL E25 CLONE PSVIE26 -CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL E25 CLONE PSVIE26 -CHAIN, DIMER
OMALIZUMAB (GENETICAL RECOMBINATION)
OMALIZUMAB [EMA EPAR]
OMALIZUMAB [INN]
OMALIZUMAB [JAN]
OMALIZUMAB [MART.]
OMALIZUMAB [MI]
OMALIZUMAB [PURPLE BOOK CDER]
OMALIZUMAB [USAN]
OMALIZUMAB [VANDF]
OMALIZUMAB [WHO-DD]
OMALIZUMAB BIOSIMILAR - GLENMARK PHARMACEUTICALS
OMALIZUMAB BIOSIMILAR - SYNERMORE
OMALIZUMAB BIOSIMILAR (CT-P39)
OMALIZUMAB-IGEC
OMLYCLO
RG-3648
RHUMAB-E25
SYN008
SYN-008
XOLAIR

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

OMALIZUMAB

Synonyms and Mappings

Resources